drugset / Trial / NCT02250612
SYL040012, Treatment for Open Angle Glaucoma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this double-masked, randomized, controlled study is to assess the safety and ocular hypotensive efficacy of four different doses of SYL040012 (bamosiran) eye drops compared to Timolol maleate 0.5% after 28 treatment days in patients with elevated intraocular pressure.
Timeline
- Start
- 2014-10
- Primary completion
- 2015-08
- Completion
- 2016-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Timolol | Other / unclassified | 0.5 % | Topical |
| Subject | bamosiran | Unknown | 0.375 % | Topical |
| Subject | bamosiran | Unknown | 0.75 % | Topical |
| Subject | bamosiran | Unknown | 1.125 % | Topical |
| Subject | bamosiran | Unknown | 1.5 % | Topical |